by Riley Nolan | Mar 11, 2021 | Events, Featured, Webinars
Aimee Mattei, Senior Project Manager on our Bioinformatics team, will be presenting to the AAPS BPABC(biopharmaceutical product attributes and biological consequences) Community on March 18th at 12pm ET. You’ll need to join the group to register, membership is...
by Riley Nolan | Feb 25, 2021 | Featured, Thinking Out Loud -Blog
When EpiVax CEO/CSO Annie De Groot began her decades-long focus on HIV vaccine research in the early 90’s, she couldn’t have predicted the implications for the COVID-19 pandemic…. Or perhaps she did! Interviewed by Michael Dumiak for August 2020 issue of IAVI, Annie...
by Riley Nolan | Feb 22, 2021 | Featured, Thinking Out Loud -Blog
Annie De Groot, CEO/CSO for EpiVax Inc, had a chance to sit down(virtually!) with Richard Asinof of CovergenceRI and Frank Casale, regional VP of TD Bank to discuss some big developments over at Clínica Esperanza. Clínica Esperanza, “Hope Clinic,” is located in the...
by Riley Nolan | Feb 18, 2021 | Featured, Thinking Out Loud -Blog
Zoom Fatigue is REAL! Like you, we’ve been insanely busy with virtual conferences in the last few weeks. We are all REALLY looking forward to meeting in person again. Meanwhile, my Zoom-buddy Jack has become quite the lap(top)-dog! The good news is that...
by Riley Nolan | Feb 17, 2021 | Featured, News
PROVIDENCE, RI, February 17, 2021 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) today announces its participation in the INDIGO consortium – a partnership of public and private research and development organizations from the EU, India, and United States (funded by the...
by Riley Nolan | Feb 17, 2021 | Events, Featured, Webinars
EpiVax CEO/CSO Annie De Groot hosted a talk for the FDA Office of Tissues and Advanced Therapies (OTAT) group on February 11, 2021. Annie presented the latest on EpiVax’s iVAX Toolkit in her talk “Epitope Selection for Cancer Vaccines”. JanusMatrix,...
